Previous studies have demonstrated that CD24 polymorphisms are associated with an increased risk of autoimmune diseases, including systemic lupus erythematosus, multiple sclerosis, and rheumatoid arthritis (65–67). Here, CD24 is linked to rheumatoid arthritis.